# Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

> clinical trial · VERIFIED · 2026-06-12

Status: RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Recurrent Endometrial Carcinoma

- Company: National Cancer Institute (NCI)
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05950464

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.